Jan 13, 2020
RESEARCH TRIANGLE PARK – Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, will conduct the world’s first clinical trial of a recombinant bacteriophage therapy, a major milestone for the field, the…
Nov 15, 2017
Locus Biosciences, born with the help of two loans from the North Carolina Biotechnology Center, has raised $19 million in Series A funding from major investors. The round was led…
Oct 27, 2016
While Crispr-Cas9 has drawn a lot of attention, scientists are investigating other Crispr approaches that may reach doctors and patients more quickly.